Ruifen Sun | Drug Discovery and Development | Women Researcher Award

Published on by Top Pharmaceutical

Prof. Ruifen Sun | Drug Discovery and Development | Women Researcher Award

Yunnan University of Chinese Medicine | China

Prof. Ruifen Sun is a nationally recognized academic leader, medical doctor, and senior nursing scholar whose work has made a significant impact on integrated traditional Chinese and Western medicine, particularly in the prevention and treatment of tumors and other major diseases. She serves as Professor, Doctoral Supervisor, and Postdoctoral Supervisor, and is widely acknowledged as a national-level first-class professional leader in nursing education. Prof. Sun is the Head of the Master’s Program in Nursing and leads Yunnan Province’s first-class discipline of Integrated Traditional Chinese and Western Medicine Nursing, where she has played a pivotal role in shaping disciplinary development, curriculum innovation, and high-level talent cultivation.With an extensive research portfolio, Prof. Sun has published more than forty SCI-indexed papers and holds both an authorized invention patent and an authorized utility model patent, reflecting her strong capacity for scientific innovation and translational research. She has led numerous nationally and provincially funded research projects, teams, and academic platforms, including major initiatives supported by the National Natural Science Foundation of China. Her research integrates theoretical exploration with clinical application, bridging traditional Chinese medicine nursing practices and modern biomedical approaches.Prof. Sun is an active participant in the global academic community, having delivered oral presentations and engaged in scholarly exchanges at leading international conferences across Europe and North America. She has also served as a state-sponsored visiting scholar at a major medical center in the United States, further strengthening her international academic vision. Beyond academia, she is a member of the National Traditional Chinese Medicine Standards Advisory Expert Database and a distinguished young talent under Yunnan Province’s high-level talent program. She has additionally contributed to regional governance through public service leadership roles. Currently, she serves as Dean of the School of Nursing at Yunnan University of Traditional Chinese Medicine and leads its Overseas Students Association, continuing to influence nursing education, research excellence, and international collaboration.

Citation Metrics (Scopus)

900

700

500

300

100

0

Citations
884

Documents
46

h-index
19

Citations
Documents
h-index


View Scopus Profile View Google Scholar Profile View ORCID Profile

Featured Publications

Ruby Anto | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Ruby Anto | Drug Discovery and Development | Best Researcher Award

Centre of Excellence in Nutraceuticals | India

Dr. Ruby Anto is a distinguished biochemist and cancer researcher with an extensive career dedicated to advancing the fields of molecular oncology, bioimmunotherapy, and nutraceutical science. She currently serves as Chief Scientist at the Centre of Excellence in Nutraceuticals, KSCSTE, Government of Kerala, Thiruvananthapuram, and Honorary Scientist at the Institute of Advanced Virology, Thiruvananthapuram. Over her accomplished career, she has held numerous scientific positions at the Rajiv Gandhi Centre for Biotechnology, progressing from Research Associate to Scientist G, reflecting her consistent contributions and leadership in biomedical research.Dr. Anto earned her PhD in Biochemistry from Amala Cancer Research Centre, Thrissur, following her postgraduate studies in Chemistry and Education. Her multidisciplinary academic background—combining chemistry, biochemistry, and pedagogy—has been central to her innovative approach to cancer biology and molecular medicine. Her early academic achievements and later professional experiences at prestigious institutions such as the M.D. Anderson Cancer Center, Houston, provided a strong foundation for her research on targeted cancer therapies, chemopreventive agents, and the role of natural products in disease modulation.Recognized nationally and internationally for her scientific excellence, Dr. Anto has received several prestigious honors, including the Young National Women Bio-Scientist Award from the Department of Biotechnology, Government of India, and fellowships from the National Academy of Sciences, India, and the Academy of Sciences, Thiruvananthapuram. Her professional journey also includes global training experiences, such as her participation in the Clinical Trials Traineeship Program at INSERM, Paris, which broadened her expertise in translational research and clinical validation of nutraceutical interventions.As a mentor, Dr. Anto has nurtured a generation of young scientists, with her students and postdoctoral fellows earning numerous national and international awards for their work in cancer biology and nutraceutical research. Her leadership has fostered a thriving academic environment focused on the discovery and characterization of bioactive compounds from natural sources with therapeutic potential.Dr. Anto’s scientific publications have advanced understanding in areas such as natural compound-mediated cancer prevention, signaling pathway modulation, and anti-inflammatory mechanisms of nutraceuticals. Through her research, she continues to bridge the gap between basic biochemistry and applied health sciences, promoting nutraceutical innovation as a cornerstone of preventive and personalized medicine. Her lifelong dedication to scientific inquiry and mentorship underscores her status as one of India’s leading voices in biochemistry and nutraceutical research.

Profile: Google Scholar

Featured Publications

Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., & Kuttan, R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters, 94(1), 79–83.

Anto, R. J., Mukhopadhyay, A., Denning, K., & Aggarwal, B. B. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23(1), 143–150.

Anto, R. J., Sukumaran, K., Kuttan, G., Rao, M. N. A., Subbaraju, V., & Kuttan, R. (1995). Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Letters, 97(1), 33–37.

Oommen, S., Anto, R. J., Srinivas, G., & Karunagaran, D. (2004). Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. European Journal of Pharmacology, 485(1–3), 97–103.*

Anto, R. J., Mukhopadhyay, A., Shishodia, S., Gairola, C. G., & Aggarwal, B. B. (2002). Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: Correlation with induction of cyclooxygenase-2. Carcinogenesis, 23(9), 1511–1518.*

Bava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D., & Anto, R. J. (2005). Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κB and the serine/threonine kinase Akt and is independent of tubulin polymerization. Journal of Biological Chemistry, 280(8), 6301–6308.*

Srinivas, G., Anto, R. J., Srinivas, P., Vidhyalakshmi, S., Senan, V. P., & Karunagaran, D. (2003). Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. European Journal of Pharmacology, 473(2–3), 117–125.*

Liangxing Tu | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Liangxing Tu | Drug Delivery Systems | Best Researcher Award

Jiangxi University of Chinese Medicine | China

Prof. Dr. Liangxing Tu is a distinguished pharmaceutical scientist recognized for his extensive contributions to drug delivery systems and biopharmaceutics. He earned his Ph.D. in Pharmaceutics from the Shanghai University of Traditional Chinese Medicine, where he developed a strong foundation in advanced pharmaceutical formulations and nanotechnology-based therapeutics. After completing his doctoral studies, he began his professional journey at FosunPharma in Shanghai, where he contributed to pharmaceutical innovation and product development. He later joined the Jiangxi University of Traditional Chinese Medicine, where he currently serves as the Director of the Division of Innovative Pharmaceutical Sciences, leading cutting-edge research in formulation science and nanomedicine.Dr. Tu’s research focuses on developing advanced drug delivery systems, including nanocrystals, polymeric micelles, and vesicular systems, to enhance the oral bioavailability and therapeutic efficacy of poorly soluble drugs. His work also extends to exploring biopharmaceutics mechanisms to improve the in vivo performance of active pharmaceutical ingredients. His innovative approaches have positioned him at the forefront of translational pharmaceutics, bridging the gap between laboratory research and clinical applications.He is an active member of the Chinese Pharmaceutical Association and contributes his expertise as a member of the Elsevier Advisory Panel. Additionally, he serves on the Editorial Board of Chinese Chemical Letters (ISSN: 1001-8417), reflecting his strong academic presence and influence in the pharmaceutical sciences community. Dr. Tu has been awarded multiple research grants, including projects funded by the National Natural Science Foundation of China and other governmental bodies, underscoring the national and international recognition of his research excellence.Dr. Tu has published around 30 peer-reviewed papers in top-tier journals such as Chinese Chemical Letters, Drug Delivery, and the International Journal of Pharmaceutics. His representative publications include “Vesicular Drug Delivery Systems for Oral Absorption Enhancement,” “Multi-functional Chitosan Copolymer Modified Nanocrystals as Oral Andrographolide Delivery Systems for Enhanced Bioavailability and Anti-inflammatory Efficacy,” “Fabrication of Ultra-Small Nanocrystals by Formation of Hydrogen Bonds: In Vitro and In Vivo Evaluation,” “Multi-functional Chitosan Polymeric Micelles as Oral Paclitaxel Delivery Systems for Enhanced Bioavailability and Anti-Tumor Efficacy,” and “Study on the Preparation of Stabilizer-Free Silymarin Nanocrystals and Its Oral Absorption Mechanisms.”

Profile: Orcid

Featured Publications

Wang, J., Sun, Y., Meng, L., Feng, J., Cheng, M., & Tu, L. Intestinal transporters and oral absorption enhancing strategies based on these transporters. Chinese Chemical Letters.

Li, Z., Yao, L., Liu, Z., Wang, L., Ruan, H., Shen, Y., Zhang, P., Li, K., Wang, H., Fan, L., et al. Andrographolide Sulfonates and Xiyanping: A Review of Chemical Composition, Pharmacological Activities, Clinical Applications, and Adverse Reactions. Pharmaceuticals.

Tu, L., Wang, J., Sun, Y., & Wan, Y. Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport. AAPS PharmSciTech.

Zou, L., Cheng, M., Hu, K., Feng, J., & Tu, L. Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters.

He, Y., Cheng, M., Yang, R., Li, H., Lu, Z., Jin, Y., Feng, J., & Tu, L. Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane. Pharmaceutics.

Liu, W., Cheng, M., Yuan, F., He, J., Feng, Y., Jin, Y., Yang, S., Feng, J., & Tu, L. Enhancing oral bioavailability of andrographolide via sodium dodecyl sulfate and D-α-Tocopherol polyethylene glycol 1000 succinate copolymer modified nanocrystals. Journal of Drug Delivery Science and Technology.

Liu, W., Cheng, M., Lu, Z., Li, H., Feng, Y., Jin, Y., Yang, S., Feng, J., & Tu, L. Multi-functional chitosan copolymer modified nanocrystals as oral andrographolide delivery systems for enhanced bioavailability and anti-inflammatory efficacy. Drug Delivery.

Basant Farag | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Basant Farag | Drug Discovery and Development | Best Researcher Award

Zagazig University Faculty of Science | Egypt

Dr. Basant Farag is a distinguished organic chemist and assistant lecturer at the Department of Chemistry, Faculty of Science, Zagazig University, Egypt, with extensive expertise in the synthesis, biological evaluation, and computational studies of heterocyclic compounds. She completed her Ph.D. in Organic Chemistry at Zagazig University, building on her M.Sc. and B.Sc. degrees in the same field, demonstrating a consistent commitment to advancing chemical sciences. Her academic career encompasses teaching, mentoring students, and conducting cutting-edge research while serving as a teaching assistant and assistant lecturer, preparing lectures, evaluating students, and engaging in independent research projects. Dr. Farag is also an accomplished international reviewer for numerous journals including Chemistry Select, Eurasian Journal of Chemistry, Journal of Molecular Structure, Bioorganic Chemistry, and International Journal of Biological Macromolecules, highlighting her broad expertise and recognition in the global scientific community.Her research portfolio includes pioneering studies in the design and synthesis of biologically active heterocyclic compounds, focusing on pharmacologically relevant molecules with anticancer, antimicrobial, and antitubercular properties. Her notable publications include Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase, Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents, Green Synthesis and Molecular Docking Study of Some New Thiazoles Using Terephthalohydrazide Chitosan Hydrogel as Ecofriendly Biopolymeric Catalyst, Green Route Synthesis and Molecular Docking of Azines Using Cellulose Sulfuric Acid under Microwave Irradiation, Synthesis, Molecular Docking and Anticancer Activity of Some 5-Aryl-5,10-Dihydropyrido[2,3-d:6,5-d′]Dipyrimidine-2,4,6,8-Tetraone Derivatives and Pyrido[2,3-d], Synthesis, Molecular Docking Study, and Biological Evaluation of New Thiadiazole and Thiazole Derivatives Incorporating Isoindoline-1,3-Dione Moiety as Anticancer and Antimicrobial Agents, Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis, Cyanauric Chloride as a Key Precursor and a Core Component for Three-Armed Triazolopyrimidines: Recent Finding About SARs and Docking Analyses, Chitosan–Sulfonic Acid-Catalyzed Green Synthesis of Naphthalene-Based Azines as Potential Anticancer Agents, Synthesis, Molecular Docking, In Silico Study, and Evaluation of Bis-Thiazole-Based Curcumin Derivatives as Potential Antimicrobial Agents, and Design and Synthesis of Novel Hybrids Incorporating Thiadiazole or Thiazole-Naphthalene: Anticancer Assessment and Molecular Docking Study.

Profile: Google Scholar

Featured Publications

Abolibda, T. Z., Fathalla, M., Farag, B., Zaki, M. E. A., & Gomha, S. M. (n.d.). Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase. Molecules.

Ibrahim, M. S., Farag, B., Al-Humaidi, J. Y., Zaki, M. E. A., Fathalla, M., & Gomha, S. M. (n.d.). Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents. Molecules.

Gomha, S. M., Riyadh, S. M., Alharbi, R. A. K., Zaki, M. E. A., Abolibda, T. Z., & Farag, B. (n.d.). Green route synthesis and molecular docking of azines using cellulose sulfuric acid under microwave irradiation. Crystals.

Al-Humaidi, J. Y., Gomha, S. M., El-Ghany, N. A. A., Farag, B., Zaki, M. E. A., et al. (n.d.). Green synthesis and molecular docking study of some new thiazoles using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst. Catalysts.

Hussein, A. M., Gomha, S. M., El-Ghany, N. A. A., Zaki, M. E. A., Farag, B., et al. (n.d.). Green biocatalyst for ultrasound-assisted thiazole derivatives: Synthesis, antibacterial evaluation, and docking analysis. ACS Omega.

Mokbel, W. A., Hosny, M. A., Gomha, S. M., Zaki, M. E. A., Farag, B., El Farargy, A. F., et al. (n.d.). Synthesis, molecular docking study, and biological evaluation of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents. Results in Chemistry.

Jun Liu | Pharmaceutical Manufacturing | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Jun Liu | Pharmaceutical Manufacturing | Best Researcher Award

Nanchang University | China

Dr. Jun Liu is a distinguished scholar specializing in Forest Products Chemical Processing Engineering, having earned his Ph.D. from Beijing Forestry University. Following his doctoral studies, he pursued advanced postdoctoral research in Power Engineering and Engineering Thermophysics at the Institute of Engineering Thermophysics, Chinese Academy of Sciences. Currently, he serves as the Deputy Director and Secretary of the Party Branch in the Department of Process Equipment and Control Engineering at the School of Resources and Environment, Nanchang University, where he has become an influential figure driving research and academic innovation.A prolific contributor to scientific literature, Dr. Liu has authored and co-authored several influential publications in high-impact journals. Some of his notable works include AHP-Optimized Processing Technology and Quality Evaluation System for Rehmanniae Radix published in LWT-Food Science and Technology, Analysis of the Microscopic Interactions Between Processed Polygonatum Cyrtonema Polysaccharides and Water featured in the Journal of Molecular Graphics and Modelling, and Development and Application of the New Integrated Equipment and Process of the Nine-Steam-Nine-Bask Method in the Processing of Polygonatum Cyrtonema published in Processes.Dr. Liu’s research spans a wide spectrum of topics, including the study of chemical components in traditional Chinese medicine, quality control and standardization, resource utilization, computer simulation, intelligent manufacturing, and related interdisciplinary areas. He has successfully led and contributed to numerous national and provincial research projects focusing on innovative processing technologies for medicinal plants, solar-assisted heat pump drying systems, and integrated cultivation and processing technologies for medicinal resources. His efforts have advanced both theoretical knowledge and practical applications in chemical processing engineering, particularly in the field of traditional Chinese medicine and sustainable resource utilization.

Profile: Orcid

Featured Publications

Hu, X., Hu, Z., Tu, W., Huang, Z., Pan, Q., Liu, J., & Deng, T. (2025). AHP-optimized processing technology and quality evaluation system for Rehmanniae Radix. LWT.

Liu, J., Chen, C., Tu, W., Liu, W., & Zhang, Y. (2023). Analysis of the microscopic interactions between processed Polygonatum cyrtonema polysaccharides and water. Journal of Molecular Graphics and Modelling.

Liu, J., Zhang, Z., Huai, X., Wei, Y., Zhu, J., Li, X., Xu, P., & Ijabadeniyi, O. A. (2022). Development and application of the new integrated equipment and process of the Nine-Steam-Nine-Bask method in the processing of Polygonatum cyrtonema. Processes.

Liu, J. (2019). Preparation of double-layered structural materials with partially reduced graphene oxide and their application in the photothermal evaporation process. Science of Advanced Materials.

Liu, J. (n.d.). Molecular structure and spectral characteristics of hyperoside and analysis of its molecular imprinting adsorption properties based on density functional theory.

Jinyu Liu | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Jinyu Liu | Drug Discovery and Development | Best Researcher Award

School of Public Health Jilin University | China

Mr. Jinyu Liu is a distinguished scholar in the fields of stem cell biology, regenerative medicine, toxicology, tissue engineering, and tumor pathobiology. He began his academic journey at the N. Bethune University of Medical Sciences, where he successfully completed his MD, followed by a Master’s degree in Toxicology and a Ph.D. in Biochemistry at the Institute of Regenerative Medicine. Building on this strong academic foundation, he embarked on an extensive research and teaching career across several leading institutions globally.Mr. Liu’s professional path includes serving as an Environmental Protection Engineer at the Songliao Water Conservancy Agency before moving into academic research and teaching. He held research positions at Zurich University Hospital in Switzerland, where he contributed significantly to studies in dermatology and regenerative medicine, followed by a research faculty position at the State University of New York at Buffalo in the Department of Biological and Chemical Engineering. Returning to China, he joined Jilin University, holding roles such as Vice Chair of the Department of Pathobiology, Chair of the Department of Toxicology, and later Professor at the School of Public Health, where he continues to teach and mentor future scientists.Throughout his career, Mr. Liu has contributed extensively to scientific literature with publications spanning diverse research areas. His works include studies on PBX1 attenuating MeHg-induced SH-SY5Y cell apoptosis, AT-PBX1 fusion protein alleviating LPS-induced acute lung injury, and viral hijacking of host DDX60 promoting Crimean-Congo hemorrhagic fever virus replication. He has explored type 3 diabetes and metabolic reprogramming of brain neurons, neurotoxic β-amyloid oligomers causing mitochondrial dysfunction in neurons, and research on the development and regeneration of hair follicles. His studies have also examined circadian clock regulation in hair follicle cycles, the role of PBX1 in mammalian kidneys, oxidative stress modulation in mesenchymal stem cells, and CRISPR-Cas12a-based detection of monkeypox virus.

Profile: Orcid

Featured Publications

Chen, Z., Liu, X., Zuo, K., Xin, Y., & Liu, J. (2025). TAT-PBX1 fusion protein alleviates LPS-induced acute lung injury via AMPK-TFAM signaling activation. Molecular Therapy.

Sui, Y., Marzi, A., Xu, Q., Liu, M., Liu, X., Liu, X., Wang, Y., Meng, X., Liu, Z., Li, Q., et al. (2025). Viral hijacking of host DDX60 promotes Crimean-Congo haemorrhagic fever virus replication via G-quadruplex unwinding. PLOS Pathogens, 21(6), e1013278.

Sui, Y., Liu, F., Zheng, S., Liu, X., Sun, P., Yao, C., Zhang, Y., Gao, H., Gao, X., & Liu, J. (2023). G-quadruplexes folding mediates downregulation of PBX1 expression in melanoma. Signal Transduction and Targeted Therapy, 8(1), 12.

Sui, Y., Xu, Q., Liu, M., Zuo, K., Liu, X., & Liu, J. (2022). CRISPR-Cas12a-based detection of monkeypox virus. Journal of Infection, 85(6), 702–769.

Ma, Y., Li, M., Liu, J., Pang, C., Zhang, J., Li, Y., & Fu, X. (2018). Location, isolation, and identification of mesenchymal stem cells from adult human sweat glands. Stem Cells International, Article ID 2090276.

Prof.Mohamed Abdel-Aziz, Drug Discovery and Development,Best Researcher Award-1133

Published on by Top Pharmaceutical

Prof.Mohamed Abdel-Aziz, Drug Discovery and Development ,Best Researcher Award

Prof.Mohamed Abdel-Aziz, at National Research Centre,Egypt

Author Profile

🎓 Education:

He earned his PhD in Microbiology from Ain Shams University, specializing in Physiological and Genetical Studies on Dextranase Formation by Fungi. His academic journey includes a Master’s degree from Mansoura University and a Bachelor’s degree in Botany.

🔍 Research Focus:

Dr. Abdel-Aziz’s research primarily focuses on Microbial Chemistry, with extensive contributions to understanding microbial enzymes and bioactive compounds.

🌐 International Collaborations:

He has participated in several scientific missions and collaborations worldwide, including Italy, Great Britain, China, Germany, and Sweden, enriching his research with diverse perspectives.

📘 Publications:

Dr. Abdel-Aziz has authored over 145 publications, including original articles, reviews, and books, notably contributing to advancements in microbiology and biotechnology.

🏆 Achievements:

He holds seven patents and has been involved in numerous national and international research projects, enhancing the field’s knowledge and applications.

🌟 Recognition:

With an h-index of 31 and over 3000 citations, his work continues to influence the scientific community globally.

🎓Publication Top Noted:

Paper Title : Effect of plasma superficial treatments on antibacterial functionalization and coloration of cellulosic fabrics

  • Authors: Eid B. M. and Abdel-Aziz M. S. Ibrahim N. A.
  • Journal: Applied Surface Science
  • Year: 2017
Paper Title :Preparation of polystyrene nanocomposites based on silver nanoparticles using marine bacterium for packaging
    • Authors: Ahmed M Youssef, Mohamed S Abdel-Aziz
    • Journal:Polymer-Plastics Technology and Engineering
    • Year: 2013
Paper Title : Seven naphtho-γ-pyrones from the marine-derived fungus Alternaria alternata: structure elucidation and biological properties
  • Authors: Mohamed Shaaban, Khaled A Shaaban, Mohamed S Abdel-Aziz
  • Journal:Organic and medicinal chemistry letters
  • Year: 2012
Paper Title :Seven naphtho-γ-pyrones from the marine-derived fungus Alternaria alternata: structure elucidation and biological properties
  • Authors: Mohamed Shaaban, Khaled A Shaaban, Mohamed S Abdel-Aziz
  • Journal:Organic and medicinal chemistry letters
  • Year: 2012

Paper Title :Design, synthesis and biological investigation of certain pyrazole-3-carboxylic acid derivatives as novel carriers for nitric oxide

  • Authors: El-Shimaa MN Abdel-Hafez, Gamal El-Din AA Abuo-Rahma, Mohamed Abdel-Aziz, Mohamed F Radwan, Hassan H Farag
  • Journal:Bioorganic & medicinal chemistry
  • Year: 2009